ALEOR Dermaceuticals

Vadodara, India Founded: 2016 • Age: 10 yrs Acquired By Alembic Pharmaceuticals
Developer of therapeutic solutions for treating skin diseases

About ALEOR Dermaceuticals

ALEOR Dermaceuticals is a Healthcare company based in Vadodara (India) founded in 2016, and was acquired by Alembic Pharmaceuticals in March 2022. The company has 245 employees. Its Indian entity Aleor Dermaceuticals Limited reported revenue of β‚Ή16.23 Cr. The company was acqui-hired. Its focus areas include Life Sciences, Dermatology, Drugs and Diversified.

Company details

Developer of therapeutic solutions for treating skin diseases. The company has developed a pipeline of generic and innovative pharmaceutical drug products Clobetasol, Desonide, Lidocaine, Clobex, and more.

Operational Areas
Key Metrics

Investors in ALEOR Dermaceuticals

ALEOR Dermaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Alembic Pharmaceuticals.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Manufacturer & supplier of generic pharmaceuticals
1907alembicpharmaceuticals.comVadodara, India
Premium access

Investor details for ALEOR Dermaceuticals

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Aleor Dermaceuticals Limited (ALEOR Dermaceuticals)

Aleor Dermaceuticals Limited is the primary company behind ALEOR Dermaceuticals. The board of Aleor Dermaceuticals Limited currently have 3 directors; the longest-serving is Mitanshu Satishbhai Shah, appointed in 2016. 6 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Mitanshu Satishbhai Shah
DIN 02305207
Director23 May 201610 yrs 5 moAleor Dermaceuticals Limited
Rajkumar Shreeram Baheti
DIN 00332079
Director23 May 201610 yrs 5 moAleor Dermaceuticals Limited
Jesal Niranjan Shah
DIN 07314882
Director23 May 201610 yrs 5 moAleor Dermaceuticals Limited

Financials of ALEOR Dermaceuticals

Figures of Aleor Dermaceuticals Limited, the primary company behind ALEOR Dermaceuticals, for FY 2021. Revenue was ₹16.23 Cr (+308% year on year). Net loss was -₹79.03 Cr (-487% margin). EBITDA was -₹48.33 Cr (-298% margin). Revenue has grown at a compounded annual rate of +166% over three years.

  • ₹16.23 CrRevenue · FY 2021 · +308% YoY
  • -₹79.03 CrNet loss · -487% margin
  • -₹48.33 CrEBITDA · -298% margin
  • ₹50 LakhPaid-up capital
  • 245Employees (provident fund records)
  • +166%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Aleor Dermaceuticals Limited are on its company page.

Premium access

Detailed financial statements for ALEOR Dermaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of ALEOR Dermaceuticals

2 dated milestones of ALEOR Dermaceuticals across 6 years, from founding to its latest funding, stage changes and deals.

  1. Founded ALEOR Dermaceuticals is founded.
  2. Exit Acquired by Alembic Pharmaceuticals.

Top companies in Dermatology

2 companies that operate in the same segment as ALEOR Dermaceuticals (Dermatology) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Skincare, beauty, and wellness services provided by VLCC across multiple countries.
1989Delhi, Delhi, India
Pharmaceutical formulations for dermatology, gastroenterology, and wellness are manufactured.
2014Pune, Maharashtra, IndiaUSD 25.97 MUSD 25.91 M802
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Aleor Dermaceuticals

Premium access

Complete news archive for ALEOR Dermaceuticals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about ALEOR Dermaceuticals

ALEOR Dermaceuticals was founded in 2016.

ALEOR Dermaceuticals is headquartered in Vadodara, India. It is registered at Vadodara, Gujarat, India.

ALEOR Dermaceuticals has 245 employees.

The primary company behind ALEOR Dermaceuticals, Aleor Dermaceuticals Limited, reported revenue of β‚Ή16.23 Cr for FY 2021, up 308% year on year.

Developer of therapeutic solutions for treating skin diseases. The company has developed a pipeline of generic and innovative pharmaceutical drug products Clobetasol, Desonide, Lidocaine, Clobex, and more.

ALEOR Dermaceuticals has 1 investor. Key investors include Alembic Pharmaceuticals.

ALEOR Dermaceuticals operates through Aleor Dermaceuticals Limited.

Yes. ALEOR Dermaceuticals was acquired by Alembic Pharmaceuticals in March 2022.

The legal entities of ALEOR Dermaceuticals currently have 5 directors, including Mitanshu Satishbhai Shah, Dhananjay Madhukar Wyawahare, Rajkumar Shreeram Baheti and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available